Use of amantadine in a patient with SARS‐CoV‐2-Reference-Cited by-同舟云学术

Use of amantadine in a patient with SARS‐CoV‐2

Published:2020-06-24 Issue:1 Volume:93 Page:110-111
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Aranda‐Abreu Gonzalo Emiliano¹^ORCID,Aranda‐Martínez José Dolores²,Araújo Ramiro³

Affiliation:

1. Centro de Investigaciones Cerebrales Universidad Veracruzana Xalapa Veracruz México

2. Centro Médico Cordobés Córdoba Veracruz México

3. Hospital da Lapa Porto Portugal

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26179

Reference4 articles.

1. Amantadine as a drug to mitigate the effects of COVID-19

2. The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID‐19, including ARDS and to reduce viral replication through lysosomal effects [published online ahead of print May 21, 2020];Brenner SR;J Med Virol

3. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

4. Does amantadine have a protective effect against COVID‐19 [published online ahead of print June 04, 2020];Cortés Borra A.;Neurol Neurochir Pol

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation;Ageing Research Reviews;2024-06

2. New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19;Virus Research;2024-02

3. Clinical characteristics and outcome of COVID-19 patients with Parkinson’s disease: a hospital-based case–control study in Shanghai, China;Frontiers in Aging Neuroscience;2023-05-05

4. Ethical challenges of clinical trials with a repurposed drug in outbreaks;Medicine, Health Care and Philosophy;2023-03-07

5. Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms;Translational Neurodegeneration;2023-01-30